Claudio Cecone Selected Research

pyromellitic dianhydride

2/2022

Stabilization and Anticancer Enhancing Activity of the Peptide Nisin by Cyclodextrin-Based Nanosponges against Colon and Breast Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudio Cecone Research Topics

Disease

3	Neoplasms (Cancer) 07/2023 - 02/2022
2	Infections 03/2023 - 08/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2023
1	Melanoma (Melanoma, Malignant) 07/2023
1	Wounds and Injuries (Trauma) 03/2023
1	Intestinal Neoplasms (Intestinal Cancer) 02/2022
1	Breast Neoplasms (Breast Cancer) 02/2022
1	Colonic Neoplasms (Colon Cancer) 02/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2021
1	Heart Failure 04/2021
1	Hypoxia (Hypoxemia) 04/2021

Drug/Important Bio-Agent (IBA)

3	CyclodextrinsIBA 07/2023 - 02/2022
1	Budesonide (Pulmicort)FDA LinkGeneric 11/2023
1	Messenger RNA (mRNA)IBA 07/2023
1	PolymersIBA 07/2023
1	LipofectamineIBA 07/2023
1	AntigensIBA 07/2023
1	Anti-Infective Agents (Microbicides)IBA 03/2023
1	methylallyl trisulfide (MATS)IBA 03/2023
1	Acyclovir (Aciclovir)FDA LinkGeneric 08/2022
1	naringeninIBA 05/2022
1	CarbonatesIBA 05/2022
1	nisin AIBA 02/2022
1	Food Additives (Food Additive)IBA 02/2022
1	nisin ZIBA 02/2022
1	pyromellitic dianhydrideIBA 02/2022
1	NisinIBA 02/2022
1	Peptides (Polypeptides)IBA 02/2022
1	Oxygen (Dioxygen)IBA 04/2021
1	laminaribioseIBA 04/2021

Therapy/Procedure

1	Immunotherapy 07/2023
1	Therapeutics 04/2021